share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer MALIK AAMIR

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer MALIK AAMIR

辉瑞 | 4：持股变动声明-高管 MALIK AAMIR
美股SEC公告 ·  09/03 18:12
Moomoo AI 已提取核心信息
On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
2024年8月31日，辉瑞公司执行副总裁Aamir Malik以每股29.01美元的价格完成了对公司普通股20,195股的出售。此次交易的总销售额约为585,857美元。出售之后，Malik在辉瑞普通股的直接持股量为29,548股。根据交易代码说明，此次出售报告是为了支付行权价格或税务责任而交付或扣留证券。
2024年8月31日，辉瑞公司执行副总裁Aamir Malik以每股29.01美元的价格完成了对公司普通股20,195股的出售。此次交易的总销售额约为585,857美元。出售之后，Malik在辉瑞普通股的直接持股量为29,548股。根据交易代码说明，此次出售报告是为了支付行权价格或税务责任而交付或扣留证券。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息